Concepedia

Markus Haberger

MH

Statistics

Publications

25

Citations

1.5K

H-Index

21

Active since

2007

Affiliations

Roche Pharma AG (Germany)(Current)

Leiden University Medical Center

Roche (Switzerland)

Netherlands Metabolomics Centre

Vrije Universiteit Amsterdam

Markus Haberger is an author at Roche Pharma AG (Germany) specializing in biochemistry, antibody characterization, and life sciences.

Publications per year

2007–2023

25

Publications

25

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 1: Separation-based methods

Dietmar Reusch, Markus Haberger, B.P.K. Maier et al. · mAbs · 2014 · 164 citations · Full text

, , +17

Assessment of chemical modifications of sites in the CDRs of recombinant antibodies

Markus Haberger, Katrin Bomans, Katharina Diepold et al. · mAbs · 2014 · 162 citations · Full text

, , +17

Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry

Markus Haberger, Anna-Katharina Heidenreich, Oxana Pester et al. · mAbs · 2015 · 139 citations · Full text

, , +17

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods

Dietmar Reusch, Markus Haberger, David Falck et al. · mAbs · 2015 · 128 citations · Full text

, , +17

Linkage-Specific Sialic Acid Derivatization for MALDI-TOF-MS Profiling of IgG Glycopeptides

Noortje de Haan, Karli R. Reiding, Markus Haberger et al. · Analytical Chemistry · 2015 · 121 citations · Full text

, , +17

1–5 of 25